PRALYBRI
LIVE
Serial Number
98222576
Owner
Acadia Pharmaceuticals, Inc.Attorney
Carissa L. WeissFiling Date
Oct 13, 2023
PRALYBRI Trademark
Serial Number: 98222576
PRALYBRI is a trademark filed by
Acadia Pharmaceuticals, Inc.
on October 13, 2023. The trademark is classified under Class 5 (Pharmaceuticals).
The application is currently pending registration.
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
CARISSA L. WEISS LAW OFFICE OF CARISSA L. WEISS, PLLC
745 FIFTH AVENUE, SUITE 500
NEW YORK, NY 10151
UNITED STATES
Trademark Details
Filing Date
October 13, 2023
Registration Date
Not Registered
Goods & Services
Pharmaceutical products and preparations for the treatment of Prader-Willi syndrome (PWS) and related metabolic and neurodevelopmental disorders; pharmaceutical products and preparations for the treatment of neurodevelopmental and metabolic disorders
Filing History
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Apr 21, 2026 RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jan 23, 2026 RCCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jul 22, 2025 RCSC
ASSIGNED TO EXAMINER
Jul 15, 2025 DOCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Apr 16, 2025 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jan 31, 2025 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jul 12, 2024 GNS3
LETTER OF SUSPENSION E-MAILED
Jul 12, 2024 GNSL
SUSPENSION LETTER WRITTEN
Jul 12, 2024 CNSL
EXAMINER'S AMENDMENT ENTERED
Jul 12, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 12, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Jul 12, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jul 12, 2024 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 31, 2024 GNRN
NON-FINAL ACTION E-MAILED
May 31, 2024 GNRT
NON-FINAL ACTION WRITTEN
May 31, 2024 CNRT
ASSIGNED TO EXAMINER
May 31, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 17, 2023 NWOS
NEW APPLICATION ENTERED
Oct 17, 2023 NWAP
